291 related articles for article (PubMed ID: 19067713)
1. Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases.
Wolkenstein P; Rodriguez D; Ferkal S; Gravier H; Buret V; Algans N; Simeoni MC; Bastuji-Garin S
Br J Dermatol; 2009 Apr; 160(4):844-8. PubMed ID: 19067713
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patients.
Kodra Y; Giustini S; Divona L; Porciello R; Calvieri S; Wolkenstein P; Taruscio D
Dermatology; 2009; 218(3):215-20. PubMed ID: 19088462
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1.
Graf A; Landolt MA; Mori AC; Boltshauser E
J Pediatr; 2006 Sep; 149(3):348-53. PubMed ID: 16939745
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior.
Krab LC; Oostenbrink R; de Goede-Bolder A; Aarsen FK; Elgersma Y; Moll HA
J Pediatr; 2009 Mar; 154(3):420-5, 425.e1. PubMed ID: 18950800
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life.
Holme SA; Anstey AV; Finlay AY; Elder GH; Badminton MN
Br J Dermatol; 2006 Sep; 155(3):574-81. PubMed ID: 16911284
[TBL] [Abstract][Full Text] [Related]
6. [Managing children with neurofibromatosis type 1: what should we look for?].
Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases.
Beattie PE; Lewis-Jones MS
Br J Dermatol; 2006 Jul; 155(1):145-51. PubMed ID: 16792766
[TBL] [Abstract][Full Text] [Related]
8. Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants.
Oostenbrink R; Spong K; de Goede-Bolder A; Landgraf JM; Raat H; Moll HA
J Pediatr; 2007 Aug; 151(2):182-6, 186.e1-2. PubMed ID: 17643775
[TBL] [Abstract][Full Text] [Related]
9. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score.
Beattie PE; Lewis-Jones MS
Br J Dermatol; 2006 Dec; 155(6):1249-55. PubMed ID: 17107397
[TBL] [Abstract][Full Text] [Related]
10. The self-concept of children and adolescents with neurofibromatosis type 1.
Barton B; North K
Child Care Health Dev; 2007 Jul; 33(4):401-8. PubMed ID: 17584395
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in Swedish children with eczema.
Gånemo A; Svensson A; Lindberg M; Wahlgren CF
Acta Derm Venereol; 2007; 87(4):345-9. PubMed ID: 17598039
[TBL] [Abstract][Full Text] [Related]
12. [Neurofibromatosis in children. Our experience].
López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
[TBL] [Abstract][Full Text] [Related]
13. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
[TBL] [Abstract][Full Text] [Related]
14. Health related quality of life of a tertiary referral center population with urinary incontinence using the DCGM-10 questionnaire.
Bachmann C; Lehr D; Janhsen E; Sambach H; Muehlan H; von Gontard A; Bachmann H
J Urol; 2009 Oct; 182(4 Suppl):2000-6. PubMed ID: 19695580
[TBL] [Abstract][Full Text] [Related]
15. Quality of life, health satisfaction and family impact on caregivers of children with developmental delays.
Hsieh RL; Huang HY; Lin MI; Wu CW; Lee WC
Child Care Health Dev; 2009 Mar; 35(2):243-9. PubMed ID: 19134010
[TBL] [Abstract][Full Text] [Related]
16. Perception of disease severity in adolescents diagnosed with neurofibromatosis type 1.
Sebold CD; Lovell A; Hopkin R; Noll R; Schorry E
J Adolesc Health; 2004 Oct; 35(4):297-302. PubMed ID: 15450543
[TBL] [Abstract][Full Text] [Related]
17. Impact of peanut allergy on quality of life, stress and anxiety in the family.
King RM; Knibb RC; Hourihane JO
Allergy; 2009 Mar; 64(3):461-8. PubMed ID: 19076542
[TBL] [Abstract][Full Text] [Related]
18. [Neurofibromatosis type 1 complications in the pediatric age: follow-up of a hundred cases].
Bonnemaison E; Roze-Abert B; Lorette G; Sirinelli D; Boscq M; Mazjoub S; De Courtivron B; Bonnard C; Despert F; Toutain A; Maheut-Lourmière J; Barthez MA; Castelnau P;
Arch Pediatr; 2006 Jul; 13(7):1009-14. PubMed ID: 16716577
[TBL] [Abstract][Full Text] [Related]
19. Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1).
Szudek J; Joe H; Friedman JM
Genet Epidemiol; 2002 Aug; 23(2):150-64. PubMed ID: 12214308
[TBL] [Abstract][Full Text] [Related]
20. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children's Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI).
Walker N; Lewis-Jones MS
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):45-50. PubMed ID: 16405607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
